Loading clinical trials...
Loading clinical trials...
Randomized Controlled Study to Evaluate Safety and Efficacy of Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma
Conditions
Interventions
ologen® Collagen Matrix
Trabeculectomy with low dose mitomycin C
Locations
1
India
L V Prasad Eye Institute
Hyderabad, Telangana, India
Start Date
August 16, 2018
Primary Completion Date
April 1, 2023
Completion Date
May 19, 2023
Last Updated
December 12, 2023
NCT07396441
NCT07390890
NCT05902871
NCT06865144
NCT05564091
NCT05506423
Lead Sponsor
L.V. Prasad Eye Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions